Professional regulation: A potentially valuable tool in responding to "stem cell tourism"

Stem Cell Reports

Volumn 3, Issue 3, 2014, Pages 379-384

  Zarzeczny, Amy ^a   Caulfield, Timothy ^b   Ogbogu, Ubaka ^b   Bell, Peter ^c   Crooks, Valorie A ^d   Kamenova, Kalina ^b   Master, Zubin ^e   Rachul, Christen ^b   Snyder, Jeremy ^d   Toews, Maeghan ^b   Zoeller, Sonja ^a  

^a UNIVERSITY OF REGINA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

^d SIMON FRASER UNIVERSITY   (Canada)

^e ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GOVERNMENT REGULATION; HEALTH INSURANCE; HUMAN; LEGAL ASPECT; MEDICAL TOURISM; PATIENT EDUCATION; PHYSICIAN; PRIVATE HEALTH INSURANCE; PROFESSIONAL REGULATION; REVIEW; STEM CELL; INTERNET; LEGISLATION AND JURISPRUDENCE; STEM CELL TRANSPLANTATION;

HUMANS; INTERNET; MEDICAL TOURISM; PHYSICIANS; STEM CELL TRANSPLANTATION;

EID: 84914101489     PISSN: 22136711     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.stemcr.2014.06.016     Document Type: Review

References (48)

1. N. Amariglio, A. Hirshberg, B.W. Scheithauer, Y. Cohen, R. Loewenthal, L. Trakhtenbrot, N. Paz, M. Koren-Michowitz, D. Waldman, and L. Leider-Trejo Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient PLoS Med. 6 2009 e1000029
2. M. Arellano The rise of stem cell therapies in Mexico: inadequate regulation or unsuccessful oversight? Rev. Redbio. UNESCO 2 2012 63 78
3. Berfield, S. (2013). CellTex says it's moving its stem cell business to Mexico. Bloomberg Businessweek, January 31, 2013. http://www.businessweek.com/articles/2013-01-31/celltex-wants-to-bring-its-stem-cell-business-to-mexico.
4. P. Bianco, and D. Sipp Regulation: sell help not hope Nature 509 2014 336 337
5. I. Bourgeault, and M. Grignon A comparison of the regulation of health professional boundaries across OECD countries Eur. J. Comp. Econ. 10 2013 199 223
6. T. Caulfield, A. Zarzeczny Toronto Stem Cell Working Group Stem cell tourism and Canadian family physicians Can. Fam. Physician 58 2012 365 368 e182-e185
7. M. Chirba, and S. Garfield FDA oversight of autologous stem cell therapies: legitimate regulation of drugs and devices or groundless interference with the practice of medicine? J. Health Biomed. Law 7 2011 33 272
8. G. Cohen Protecting patients with passports: medical tourism and the patient-protective argument Iowa Law Rev. 95 2010 1467 1567
9. CPSO (College of Physicians and Surgeons of Ontario) (2011). Policy Statement #3-11, Complementary/Alternative Medicine. Approved November 1997; updated November 2011. http://www.cpso.on.ca/CPSO/media/uploadedfiles/policies/policies/policyitems/complementary-med.pdf?ext=.pdf.
10. D. Cyranoski Stem-cell therapy faces more scrutiny in China Nature 459 2009 146 147
11. De Vries, H., Sanderson, P., Janta, B., Rabinovich, L., Archontakis, F., Ismail, S., Klautzer, L., Marjanovic, S., Patruni, B., Puri, P., and Tiesse, J. (2009). International comparison of ten medical regulatory systems; Egypt, Germany, Greece, India, Italy, Nigeria, Pakistan, Poland, South Africa and Spain. UK General Medical Council. Rand Corporation. http://www.gmc-uk.org/International-Comparison-of-Ten-Medical-Regulatory-Systems---final-report.pdf-25404378.pdf.
12. B.H. Dobkin, A. Curt, and J. Guest Cellular transplants in China: observational study from the largest human experiment in chronic spinal cord injury Neurorehabil. Neural Repair 20 2006 5 13
13. FDA (U.S. Food and Drug Administration). (2011). Owner of Arizona company charged and convicted of introducing an unapproved new drug - stem cells - into interstate commerce [U.S. Department of Justice Press Release]. http://www.fda.gov/ICECI/CriminalInvestigations/ucm268867.htm.
14. GMC (General Medical Council). (2010). Re Dr Robert Theodore Henri Kees TROSSEL Reg. No. 6049460. Fitness to Practise Panel Minutes [Fitness to Practise Panel of the Medical Practitioners Tribunal Service, General Medical Council]. http://www.casewatch.org/foreign/trossel/sanction.pdf.
15. ISSCR (International Society for Stem Cell Research) (2008a). Patient handbook on stem cell therapies; Appendix I of the guidelines for the clinical translation of stem cells. http://www.isscr.org/home/publications/patient-handbook.
16. ISSCR (International Society for Stem Cell Research) (2008b). Guidelines for the clinical translation of stem cells. http://www.isscr.org/home/publications/ClinTransGuide.
17. ISSCR (International Society for Stem Cell Research) (2013). Statement on delivery of unproven autologous cell-based interventions to patients. http://www.isscr.org/docs/default-source/isscr-statements/isscr-acbistatement-091113-fl.pdf.
18. Jabr, F. (2012). In the flesh: the embedded dangers of untested stem cell cosmetics. Scientific American, December 17, 2012. http://www.scientificamerican.com/article/stem-cell-cosmetics/.
19. R. Johnston, V.A. Crooks, and J. Snyder "I didn't even know what I was looking for": A qualitative study of the decision-making processes of Canadian medical tourists Global. Health 8 2012 23
20. A. Khaliq, A. Mwachofi, and R. Broyles Physician autonomy vs. self-regulation: you can't have one without the other Ethics Med. 26 2010 111 120
21. D. Lau, U. Ogbogu, B. Taylor, T. Stafinski, D. Menon, and T. Caulfield Stem cell clinics online: the direct-to-consumer portrayal of stem cell medicine Cell Stem Cell 3 2008 591 594
22. A.D. Levine, and L.E. Wolf The roles and responsibilities of physicians in patients' decisions about unproven stem cell therapies J. Law Med. Ethics 40 2012 122 134
23. O. Lindvall, and I. Hyun Medical innovation versus stem cell tourism Science 324 2009 1664 1665
24. Master, Z., and Caulfield, T. (2014). Patient Booklet: What you need to know about stem cell therapies. http://www.hli.ualberta.ca/Research/Public-Outreach-Award.aspx.
25. Z. Master, and D.B. Resnik Stem-cell tourism and scientific responsibility. Stem-cell researchers are in a unique position to curb the problem of stem-cell tourism EMBO Rep. 12 2011 992 995
26. Medical Board of California (MBC). (2007). In the Matter of the Accusation against Darryl Matthew See, M.D. Division of Medical Quality, Medical Board of California, Department of Consumer Affairs, State of California. Case No. 04-2004-161179. http://www.casewatch.org/board/med/see/surrender.pdf.
27. Medical Board of Queensland (MBQ). (2010). Re Dr. Harvey Tarvydas Medical Board of Queensland v. Tarvydas [2010]. http://www.austlii.edu.au/cgi-bin/sinodisp/au/cases/qld/QCAT/2010/246.html?stem=0&synonyms=0&query=Tarvydas#fn4.
28. The Medical Profession Act (1981). Statutes of Saskatchewan, 1980-81, M-10.1, SS. 1980-81. http://www.qp.gov.sk.ca/documents/English/Statutes/Statutes/M10-1.pdf.
29. Mendick, R. (2012). Stem cell clinic that 'preyed on the vulnerable'. The Telegraph, April 8, 2012. http://www.telegraph.co.uk/health/healthnews/9192157/Stem-cell-clinic-that-preyed-on-the-vulnerable.html.
30. Munro, M. (2005). Authorities probe B.C. doctor who gave stem-cell injections. Times-Colonist, Victoria, BC, Canada, June 25, 2005. A5.
31. M. Munsie, and I. Hyun A question of ethics: Selling autologous stem cell therapies flaunts professional standards Stem Cell Res. (Amst.) 2014 10.1016/j.scr.2014.04.014
32. U. Ogbogu, C. Rachul, and T. Caulfield Reassessing direct-to-consumer portrayals of unproven stem cell therapies: is it getting better? Regen. Med. 8 2013 361 369
33. OMB (Oregon Medical Board) (2014). Order of emergency suspension. January 9, 2014. https://techmedweb.omb.state.or.us/Clients/ORMB/OrderDocuments/c932b921-8108-4d9f-996f-b661b81a3633.pdf.
34. Park, M. (2012). Texas board approves rules on use of stem cells. The New York Times, April 13, 2012. http://www.nytimes.com/2012/04/14/us/new-rules-on-adult-stem-cells-approved-in-texas.html.
35. J. Patenaude, A.M. Grant, M. Xhignesse, F. Leblanc, and J. Courteau Evaluation of clinical innovation: a gray zone in the ethics of modern clinical practice? J. Gen. Intern. Med. 23 Suppl 1 2008 27 31
36. A.C. Regenberg, L.A. Hutchinson, B. Schanker, and D.J. Mathews Medicine on the fringe: stem cell-based interventions in advance of evidence Stem Cells 27 2009 2312 2319
37. K.A. Ryan, A.N. Sanders, D.D. Wang, and A.D. Levine Tracking the rise of stem cell tourism Regen. Med. 5 2010 27 33
38. SMC (Singapore Medical Council). (2010a). Disciplinary Inquiry for Dr. Wong Yoke Meng. November 3, 2010. http://www.healthprofessionals.gov.sg/content/dam/hprof/smc/docs/press-releases/14.Press%20Release-Dr%20Wong%20Yoke%20Meng-3Nov10.pdf.
39. SMC (Singapore Medical Council). (2010b). Press Release: Disciplinary inquiry for Dr. Wong Yoke Meng. November 9, 2010. http://www.healthprofessionals.gov.sg/content/dam/hprof/smc/docs/press-releases/15.Press%20Release-Dr%20Wong%20Yoke%20Meng4-9Nov10.pdf.
40. J. Snyder, V.A. Crooks, R. Johnston, and P. Kingsbury What do we know about Canadian involvement in medical tourism? A scoping review Open Med. 5 2011 e139 e148
41. J. Snyder, V. Crooks, and R. Johnston Perceptions of the ethics of medical tourism: comparing patient and academic perspectives Public Health Ethics 5 2012 38 46
42. N. Stafford Germany tightens law on stem cell treatments BMJ 339 2009 b2967
43. W.M. Sullivan Medicine under threat: professionalism and professional identity CMAJ 162 2000 673 675
44. D. Thirabanjasak, K. Tantiwongse, and P.S. Thorner Angiomyeloproliferative lesions following autologous stem cell therapy J. Am. Soc. Nephrol. 21 2010 1218 1222
45. B. Tuch, and D. Wall Self-regulation of autologous cell therapies Med. J. Aust. 200 2014 196
46. J.M. Wilson Medicine. A history lesson for stem cells Science 324 2009 727 728
47. A. Zarzeczny, and T. Caulfield Stem cell tourism and doctors' duties to minors - a view from Canada Am. J. Bioeth. 10 2010 3 15
48. A. Zarzeczny, C. Rachul, M. Nisbet, and T. Caulfield Stem cell clinics in the news Nat. Biotechnol. 28 2010 1243 1246